Psoriasis in a Patient on Peritoneal Dialysis: a Two-sided Mirror

Authors

  • Laurynas Rimsevicius Faculty of Medicine, Vilnius University; Nephrology Center, Vilnius University Hospital Santariskiu klinikos; Vilnius, Lithuania Author
  • Diana Sukackiene Faculty of Medicine, Vilnius University; Nephrology Center, Vilnius University Hospital Santariskiu klinikos; Vilnius, Lithuania Author
  • Giedre Tamulyte Faculty of Medicine, Vilnius University, Vilnius, Lithuania Author
  • Greta Kirkilaite Faculty of Medicine, Vilnius University, Vilnius, Lithuania Author
  • Marius Miglinas Faculty of Medicine, Vilnius University; Nephrology Center, Vilnius University Hospital Santariskiu klinikos; Vilnius, Lithuania Author

Abstract

Psoriasis vulgaris is not frequently seen in patients with renal replacement therapy, especially in patients on peritoneal dialysis. Dialysis also has been reported to improve psoriatic skin lesions with a much higher response rate for peritoneal dialysis than haemodialysis. Conversely, we present a case of a man who developed psoriasis after 16 months of peritoneal dialysis. Discontinuation of icodextrin as a possible factor provoking systemic inflammation had no impact on the course of the disease. In this report, we review the existing studies and counsel caution against optimistic expectations of benefits from dialysis in patients with psoriasis.

Downloads

Download data is not yet available.

Author Biography

  • Laurynas Rimsevicius, Faculty of Medicine, Vilnius University; Nephrology Center, Vilnius University Hospital Santariskiu klinikos; Vilnius, Lithuania
    MD PhD

Downloads

Published

2017-02-01

Issue

Section

CASE REPORT | Dialysis

How to Cite

Psoriasis in a Patient on Peritoneal Dialysis: a Two-sided Mirror. (2017). Iranian Journal of Kidney Diseases, 11(1), 70-73. https://www.ijkd.org/index.php/ijkd/article/view/2789